Cite
HARVARD Citation
Wei, J. et al. (n.d.). AB0742 Intravenous Loading and Subcutaneous Maintenance with Secukinumab Provides Sustained Improvement in Multiple Measures of Disease Activity in Subjects with Active Ankylosing Spondylitis: 52-Week Data From the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Measure 1 Study. Annals of the rheumatic diseases. pp. 1146-1147. [Online].